First it was Italy, then it was France, and now the European Union is stepping up to take a serious look at how Swiss drugmakers Roche and Novartis have handled the marketing of their eye drug Lucentis.
written on 07.05.2014
First it was Italy, then it was France, and now the European Union is stepping up to take a serious look at how Swiss drugmakers Roche and Novartis have handled the marketing of their eye drug Lucentis.
See our Cookie Privacy Policy Here